Blog
RSS FeedPosted by Michael Wonder on 14 Apr 2019
Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing
12 April 2019 - EMA has started a review of the multiple sclerosis medicine Lemtrada (alemtuzumab) following new reports of ...
Posted by Michael Wonder on 13 Apr 2019
Missing from the PBM hearings: value based drug reimbursement
11 April 2019 - This week, committees in both the Senate and House of Representatives used their power to shine ...
Posted by Michael Wonder on 11 Apr 2019
Select committee inquiry into PHARMAC would be too slow - Labour
12 April 2019 - The Government says a select committee inquiry into PHARMAC's drug-buying processes would take longer than current ...
Posted by Michael Wonder on 11 Apr 2019
Peters accuses Bennett of using people's illnesses to gain 'political points' in exchange about PHARMAC funding
11 April 2019 - Winston Peters accused Paula Bennett of using people's illnesses to gain "political points" during an exchange ...
Posted by Michael Wonder on 11 Apr 2019
Labour MP rejects claims she said Health Minister nixed PHARMAC inquiry
11 April 2019 - Labour MP health select committee chair Louisa Wall is rejecting claims she told the husband of a ...
Posted by Michael Wonder on 09 Apr 2019
Official inquiry into PHARMAC necessary
10 April 2019 - Today National MP Michael Woodhouse is set to table a motion calling on the Health Select ...
Posted by Michael Wonder on 07 Apr 2019
Health insurers welcome Coalition review on natural therapies
8 April 2019 - Health insurers have welcomed a Coalition pledge to reconsider a ban on cover for natural therapies ...
Posted by Michael Wonder on 20 Mar 2019
FDA reform: it’s time to act, but not as an independent agency
19 March 2019 - In a rare exercise in bipartisan leadership, former FDA commissioners of both political parties called, in ...
Posted by Michael Wonder on 13 Mar 2019
Women with advanced breast cancer ask health select committee for PHARMAC review
13 March 2019 - Ten women today spoke one after the other, telling a committee of MPs how desperately they ...
Posted by Michael Wonder on 06 Mar 2019
Outcomes and impacts of 10 year HTA implementation in Taiwan
28 February 2019 - In 2007, Taiwan began conducting health technology assessments to support the National Health Insurance Administration in ...
Posted by Michael Wonder on 28 Feb 2019
After 16 reviews we know how to fix health care, experts say
28 February 2019 - After 16 national reviews in 35 years, the road map for improving the health care system ...
Posted by Michael Wonder on 26 Feb 2019
Details of Doug Ford government’s health care overhaul, including new super agency, coming Tuesday
26 February 2019 - The Ontario government will announce its long-rumoured overhaul of the province’s health care system on Tuesday, ...
Posted by Michael Wonder on 26 Feb 2019
Procedural update on submission of Type I variations to EMA in March, April and May 2019
26 February 2019 - EMA is encouraging marketing authorisation holders intending to submit Brexit-related Type IA and Type IB variations ...
Posted by Michael Wonder on 13 Feb 2019
PHARMAC to review its practices following criticism of breast cancer drug funding
13 February 2019 - The government's drug-buying agency has announced it has begun an internal review following a petition and ...
Posted by Michael Wonder on 10 Feb 2019
How procurement judges the value of medical technologies: a review of health care tenders
8 February 2019 - Procurement's important role in healthcare decision making has encouraged criticism and calls for greater collaboration with health ...